跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Topoblock - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Topoblock
Approved
STANDARD
Topoblock
Venus Remedies Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
47b7acb06b867a92
Company
Venus Remedies Limited
Type
Standard
Approval Details
Approval Id
47b7acb06b867a92
Drug Approval Philippines Name
Topoblock
Product Name
Topoblock
Registration Number
DRP-4116-01
Brand Name
Topoblock
Generic Name
Irinotecan Hydrochloride
Dosage Form
Solution for Injection (IV)
Dosage Strength
20mg/mL
Manufacturer
Venus Remedies Limited
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Ellebasy Medicale Group Inc.
Company Detail Path
/organization/venus-remedies-limited
Issuance Date
28 November 2022
Expiry Date
03 November 2027
Pharmacologic Category
Anti-neoplastic (cell cycle-specific agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
47b7acb06b867a92
Type
Standard
Back to Philippines FDA Approvals